Ko, M.; Chang, S.Y.; Byun, S.Y.; Ianevski, A.; Choi, I.; Pham Hung d’Alexandry d’Orengiani, A.-L.; Ravlo, E.; Wang, W.; Bjørås, M.; Kainov, D.E.;
et al. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19. Viruses 2021, 13, 651.
https://doi.org/10.3390/v13040651
AMA Style
Ko M, Chang SY, Byun SY, Ianevski A, Choi I, Pham Hung d’Alexandry d’Orengiani A-L, Ravlo E, Wang W, Bjørås M, Kainov DE,
et al. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19. Viruses. 2021; 13(4):651.
https://doi.org/10.3390/v13040651
Chicago/Turabian Style
Ko, Meehyun, So Young Chang, Soo Young Byun, Aleksandr Ianevski, Inhee Choi, Anne-Laure Pham Hung d’Alexandry d’Orengiani, Erlend Ravlo, Wei Wang, Magnar Bjørås, Denis E. Kainov,
and et al. 2021. "Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19" Viruses 13, no. 4: 651.
https://doi.org/10.3390/v13040651
APA Style
Ko, M., Chang, S. Y., Byun, S. Y., Ianevski, A., Choi, I., Pham Hung d’Alexandry d’Orengiani, A.-L., Ravlo, E., Wang, W., Bjørås, M., Kainov, D. E., Shum, D., Min, J.-Y., & Windisch, M. P.
(2021). Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19. Viruses, 13(4), 651.
https://doi.org/10.3390/v13040651
